For 2025, our focus remains: translating new data into clinical practice.  The programme will consist of state-of-the-art lectures, case discussions and panel debates. Our faculty is a group of well-chosen international & multidisciplinary experts, who will discuss all hot topics of 2025 in renal cancer. There are no parallel sessions in order to maximise interaction. We will take you on our journey to Lisbon and beyond. Prior to the meetings, we send out case challenges, where you can compare your opinion with peers & experts. These cases will be part of the RENALC-BLADDR-PROSCA programme during the meetings (3 December for RENALC). After the meetings, you will be fully updated on renal cancer management.